BMC Nutrition,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: Aug. 9, 2023
Time-restricted
eating
(TRE)
is
a
current
popular
dietary
strategy
for
noncommunicable
diseases.
However,
studies
demonstrated
contradictory
results
it
and
in
all
strategies,
diet
quality
an
the
important
part
of
well-being.
Our
study
aimed
to
investigate
effect
TRE
energy-restricted
(ERD)
on
nutritional
status
individuals.This
pilot
was
completed
23
healthy
overweight
female.
Anthropometric
body
composition
measurements
individuals
were
taken.
The
energy
expenditure
measured
using
indirect
calorimetry.
Blood
pressure
heart
rate
made.
Biochemical
parameters
evaluated
food
consumption
intake
assessed
Healthy
Eating
Index
(HEI)
-2015.
physical
activity
levels
estimated
record.
Statistical
Package
Social
Sciences
(version
22.0)
software
used
analyses.
A
p-value
less
than
0.05
considered
be
statistically
significant.After
8
weeks
intervention,
while
no
change
observed
group
(p
>
0.05),
significant
increase
found
score
ERD
<
0.05).
There
3.2%
5.5%
decrease
weight
groups,
respectively
While
fat
percentage
7.1%
total
cholesterol
(3.7%)
group,
(6.7%)
low
density
lipoprotein
(LDL-C)
(6.5%)
group.
In
addition,
adiponectin
(77.3%)
antioxidant
(TAS)
(13.2%)
group.Energy-restricted
yielded
better
loss
improvement
compared
TRE.
Also,
level
more
should
done
with
longer
follow-ups
high
sample
sizes
are
very
terms
creating
public
health-based
recommendations.
Hepatology Communications,
Journal Year:
2023,
Volume and Issue:
7(8)
Published: Aug. 1, 2023
Background
and
Aims:
Despite
NAFLD
being
the
most
prevalent
liver
disease
globally,
currently
there
are
no
FDA-approved
treatments,
weight
loss
through
caloric
restriction
enhanced
physical
activity
is
recommended
treatment
strategy.
Intermittent
fasting
(IF)
has
been
proposed
as
an
alternative
strategy
with
additional
cardiometabolic
benefits.
In
this
systematic
review
meta-analysis,
we
evaluated
anthropometric,
biochemical,
hepatic
impacts
of
IF
in
patients
NAFLD.
Methods:
MEDLINE,
EMBASE,
Cochrane
Central,
conference
abstracts
were
searched
for
interventions
adults
until
April
2,
2023.
Meta-analysis
a
random
effects
model
was
used
to
compare
pre-intervention
post-intervention
changes
end
points
intervention
group
control
group.
Publication
bias
assessed
using
Egger’s
test.
Results:
Fourteen
studies
included
ten
meta-analysis
(n
=
840
participants,
44.64%
male).
Studies
varied
modalities
diagnosis,
duration
(4–52
weeks),
type
(5:2
diet,
modern
alternate-day
fasting,
time-restricted
eating,
or
religious
fasting).
Body
weight,
body
mass
index,
waist
hip
ratio
all
significantly
improved
following
(
p
<
0.05).
Adults
showed
improvement
serum
alanine
transaminase,
aspartate
aminotransferase,
steatosis
(controlled
attenuation
parameter
measured
by
vibration-controlled
transient
elastography),
stiffness
(measured
elastography)
after
Conclusions:
There
limited,
but
moderate-
high-quality
evidence
suggest
that
can
improve
promote
Larger
randomized
controlled
extended
needed
further
validate
our
findings.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(3), P. 357 - 357
Published: Jan. 25, 2024
The
efficacy
of
intermittent
fasting
(IF),
as
an
emerging
weight
management
strategy,
in
improving
cardiometabolic
health
has
been
evaluated
various
populations,
but
that
among
Chinese
individuals
not
systematically
studied.
A
comprehensive
search
on
multiple
databases
was
performed
to
identify
eligible
randomized
controlled
trials
(RCTs)
up
October
2022.
primary
outcome
post-intervention
loss,
and
secondary
outcomes
included
changes
indicators.
Effect
estimates
were
meta-analyzed
using
a
random-effects
model.
In
total,
nine
RCTs
with
899
participants
included.
Time-restricted
eating
the
most
adopted
IF
protocol
this
study
(six
out
nine),
followed
by
alternate-day
fasting.
intervention
significantly
reduced
body
weight,
mass
index,
fat
mass,
homeostatic
model
assessment
insulin
resistance,
low-density
lipoprotein
cholesterol,
triglycerides
when
compared
control
groups.
However,
no
statistically
significant
reductions
waist
circumference,
total
high-density
glucose,
systolic
blood
pressure,
diastolic
pressure
found.
To
sum
up,
can
be
strategy
may
improve
adults,
more
long-term
different
strategies
are
required
generate
robust
evidence
its
efficacy.
Journal of Yeungnam Medical Science,
Journal Year:
2022,
Volume and Issue:
40(1), P. 4 - 11
Published: April 4, 2022
Caloric
restriction
is
a
popular
approach
to
treat
obesity
and
its
associated
chronic
illnesses
but
difficult
maintain
for
long
time.
Intermittent
fasting
an
alternative
easily
applicable
dietary
intervention
caloric
restriction.
Moreover,
intermittent
has
beneficial
effects
equivalent
those
of
in
terms
body
weight
control,
improvements
glucose
homeostasis
lipid
profiles,
anti-inflammatory
effects.
In
this
review,
the
are
discussed.
Hepatology,
Journal Year:
2023,
Volume and Issue:
78(4), P. 1290 - 1305
Published: April 14, 2023
NASH
is
one
of
the
leading
causes
chronic
liver
disease
with
potential
evolving
towards
end-stage
and
HCC,
even
in
absence
cirrhosis.
Apart
from
becoming
an
increasingly
prevalent
indication
for
transplantation
cirrhotic
HCC
patients,
its
burden
on
healthcare
system
also
exerted
by
increased
number
noncirrhotic
patients.
Intermittent
fasting
has
recently
gained
more
interest
scientific
community
as
a
possible
treatment
approach
different
components
metabolic
syndrome.
Basic
science
clinical
studies
have
shown
that
apart
inducing
body
weight
loss,
improving
cardiometabolic
parameters,
namely
blood
pressure,
cholesterol,
triglyceride
levels;
insulin
glucose
metabolism;
intermittent
can
reduce
inflammatory
markers,
endoplasmic
reticulum
stress,
oxidative
autophagy,
endothelial
dysfunction,
well
modulate
gut
microbiota.
This
review
aims
to
further
explore
main
pathogenetic
drivers
which
act
upon
improve
prognosis
disease,
summarize
current
evidence.
Cells,
Journal Year:
2023,
Volume and Issue:
12(13), P. 1760 - 1760
Published: June 30, 2023
Multiple
sclerosis
(MS)
is
a
chronic,
progressive
neuroinflammatory
disease
with
complex
pathophysiological
background.
A
variety
of
diverse
factors
have
been
attributed
to
the
propagation
inflammation
and
neurodegeneration
in
MS,
mainly
genetic,
immunological,
environmental
such
as
vitamin
D
deficiency,
infections,
or
hormonal
disbalance.
Recently,
importance
gut-brain
axis
for
development
many
neurological
conditions,
including
stroke,
movement
disorders,
has
postulated.
The
purpose
our
paper
was
summarize
current
evidence
confirming
role
gut
microbiome
pathophysiology
MS
related
neuromyelitis
optica
spectrum
disorder
(NMO-SD).
For
this
aim,
we
conducted
systematic
review
literature
listed
following
databases:
Medline,
Pubmed,
Scopus,
were
able
identify
several
studies
demonstrating
involvement
NMO-SD.
It
seems
that
most
relevant
bacteria
are
those
belonging
Pseudomonas,
Mycoplasma,
Haemophilus,
Blautia,
Dorea,
Faecalibacterium,
Methanobrevibacter,
Akkermansia,
Desulfovibrionaceae
genera,
while
Clostridium
perfringens
Streptoccocus
demonstrated
play
Following
line
evidence,
there
also
some
preliminary
data
supporting
use
probiotics
other
agents
affecting
could
potentially
beneficial
effect
on
MS/NMO-SD
symptoms
prognosis.
topic
therefore
since
it
be
used
biomarker
progression
well
potential
disease-modifying
therapy.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(6)
Published: May 24, 2024
Abstract
White
adipose
tissue
is
not
only
a
highly
heterogeneous
organ
containing
various
cells,
such
as
adipocytes,
stem
and
progenitor
immune
but
also
an
endocrine
that
important
for
regulating
metabolic
homeostasis.
In
individuals
with
obesity,
dynamic
cellular
changes
in
result
phenotypic
switching
dysfunction,
including
pathological
expansion,
WAT
fibrosis,
cell
infiltration,
endoplasmic
reticulum
stress,
ectopic
lipid
accumulation,
ultimately
leading
to
chronic
low‐grade
inflammation
insulin
resistance.
Recently,
many
distinct
subpopulations
of
have
been
identified,
providing
new
insights
into
the
potential
mechanisms
dysfunction
obesity.
Therefore,
targeting
white
therapeutic
agent
treating
obesity
obesity‐related
diseases
great
scientific
interest.
Here,
we
provide
overview
remodeling
discuss
underlying
regulatory
dysfunction.
Currently,
studies
uncovered
promising
targets
strategies
treatment.
We
outline
signaling
pathways
summarize
existing
antiobesity
treatment
pharmacological
approaches,
lifestyle
interventions,
novel
therapies.
Trials,
Journal Year:
2024,
Volume and Issue:
25(1)
Published: March 5, 2024
Abstract
Background
Rheumatoid
arthritis
(RA)
is
known
as
a
chronic
systemic
autoimmune
disorder
that
primarily
targets
synovial
joints,
and
may
cause
pain
functional
limitations.
Studies
show
diet
can
have
beneficial
effects
on
symptoms
oxidative
stress
of
this
disease.
Intermittent
fasting
(IF)
dietary
approach
with
cycles
intake.
The
current
study
aims
to
investigate
the
effect
IF
quality
life,
clinical
symptoms,
inflammation,
in
overweight
obese
postmenopausal
women
RA.
Methods
randomized
trial,
which
44
patients
mild
moderate
severity
RA
will
be
randomly
allocated
receive
either
(
n
=
22)
or
usual
for
8
weeks.
Anthropometric
measures
biochemical
indicators
including
serum
concentrations
erythrocyte
sedimentation
rate
(ESR),
c-reactive
protein
(CRP),
total
oxidant
antioxidant
capacity
(TOC
TAC)
assessed
at
baseline
end
study.
Also,
disease
by
Disease
Activity
Score-28
(DAS-28)
activity
index
(CDAI),
disability
Health
Assessment
Questionnaire-Disability
Index
(HAQ-DI)
questionnaire.
Discussion
has
inflammatory
markers
results
an
improvement
health
different
populations.
Literature
review
shows
it
seems
there
no
field
evaluate
patients,
they
are
limited
other
types
fasting.
However,
studies
many
positive
diseases.
Therefore,
these
patients.
Trial
registration
IRCT20230217057441N1.
Registered
14
February
2023.
https://en.irct.ir/user/trial/68669
.
Journal of Internal Medicine,
Journal Year:
2022,
Volume and Issue:
295(4), P. 400 - 415
Published: June 15, 2022
Abstract
Nutrition
profoundly
influences
the
risk
for
many
age‐related
diseases.
Whether
nutrition
human
aging
biology
directly
is
less
clear.
Studies
in
different
animal
species
indicate
that
reducing
food
intake
(“caloric
restriction”
[CR])
can
increase
lifespan
and
delay
onset
of
diseases
biological
hallmarks
aging.
Obesity
has
been
described
as
“accelerated
aging”
therefore
health
benefits
generated
by
CR
both
obesity
may
occur
via
similar
mechanisms.
Beyond
calorie
intake,
studies
based
on
nutritional
geometry
have
shown
protein
interaction
between
dietary
carbohydrates
influence
lifespan.
where
animals
are
calorically
restricted
providing
free
access
to
diluted
diets
had
impact
than
those
given
a
reduced
aliquot
each
day
fasting
meals.
This
drawn
attention
role
aging,
exploration
effects
various
regimes.
Although
definitive
clinical
trials
would
need
be
unfeasibly
long
unrealistically
controlled,
there
good
evidence
from
experiments
some
interventions
CR,
manipulating
macronutrients,
Journal of Internal Medicine,
Journal Year:
2022,
Volume and Issue:
293(2), P. 166 - 183
Published: Oct. 22, 2022
Abstract
Experimental
trials
in
organisms
ranging
from
yeast
to
humans
have
shown
that
various
forms
of
reducing
food
intake
(caloric
restriction)
appear
increase
both
overall
and
healthy
lifespan,
delaying
the
onset
disease
slowing
progression
biomarkers
aging.
The
gut
microbiota
is
considered
one
key
environmental
factors
strongly
contributing
regulation
host
health.
Perturbations
composition
activity
microbiome
are
thought
be
involved
emergence
multiple
diseases.
Indeed,
many
studies
investigating
been
performed
strong
associations
between
specific
microorganisms
metabolic
diseases
including
overweight,
obesity,
type
2
diabetes
mellitus
as
well
gastrointestinal
disorders,
neurodegenerative
diseases,
even
cancer.
Dietary
interventions
known
reduce
inflammation
improve
health
potentiated
by
prior
fasting.
Inversely,
birth
weight
differential
oxidative
phosphorylation
response
fasting
implies
epigenetic
control
some
its
effector
pathways.
There
substantial
evidence
for
efficacy
improving
insulin
signaling
blood
glucose
control,
inflammation,
conditions
which,
additionally,
has
identified
a
site
risk
protective
factors.
Accordingly,
human
microbiota,
symbiont
pathobiont
roles,
proposed
impact
mediate
benefits
could
potentially
affect
these
While
results
small‐N
diverge,
consistently
enriches
widely
recognized
anti‐inflammatory
commensals
such
Faecalibacterium
other
short‐chain
fatty
acid
producers,
which
likely
mediates
effects
through
immune
system
barrier
function
impact.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: March 27, 2024
Abstract
Body
mass
index
(BMI)
is
a
crucial
health
indicator
for
obesity.
With
the
progression
of
socio-economic
status
and
alterations
in
lifestyle,
an
increasing
number
global
populations
are
at
risk
Given
complexity
severity
neurological
diseases,
early
identification
factors
vital
diagnosis
prognosis
such
diseases.
In
this
study,
we
employed
Mendelian
randomization
(MR)
analysis
utilizing
most
comprehensive
genome-wide
association
study
(GWAS)
data
to
date.
We
selected
single
nucleotide
polymorphisms
(SNPs)
that
unaffected
by
confounding
reverse
causality
as
instrumental
variables.
These
variables
were
used
evaluate
genetic
causal
relationships
between
Mass
Index
various
including
Parkinson’s
Disease
(PD),
Alzheimer's
(AD),
Amyotrophic
Lateral
Sclerosis
(ALS),
Multiple
(MS),
Ischemic
Stroke
(IS),
Epilepsy
(EP).
The
Inverse
Variance
Weighted
(IVW)
indicated
there
was
no
significant
relationship
indicators
PD
(
P
-value
=
0.511),
AD
0.076),
ALS
0.641),
EP
0.380).
However,
found
BMI
MS
0.035),
IS
0.000),
with
positively
correlated
both
Cochran’s
Q
test
MR-IVW
showed
heterogeneity
MR
results
diseases
>
0.05).
Egger
intercept
pleiotropy
revealed
horizontal
detected
any
studied
It
PD,
AD,
ALS,
EP,
MS,
IS.
Meanwhile,
increase
can
lead
higher
IS,
which
reveals
critical
role
obesity
factor
specific
pathogenesis